Wolters Kluwer N.V.

Wolters Kluwer N.V.

WOLTF
Wolters Kluwer N.V.US flagOther OTC
79.30
USD
+1.85
- -
17.91BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
12.06
12.37
14.33
14.7
15.32
15.39
17.06
17.37
18.32
21.41
22.8
24.91
26.52
Basic EPS, GAAP
1.17
1.6
1.44
1.68
2.23
2.37
2.48
2.72
2.8
4.03
4.11
4.54
5.66
Free Cash Flow per Basic Share
2.13
2.24
2.87
3.18
3.3
3.62
4.08
4.52
4.96
6.21
6.31
6.96
7.22
Dividend per Share
0.69
0.71
0.9
0.76
0.81
1
1.04
1.26
1.43
1.66
1.91
2.19
2.44
Book Value per Share
5.3
7.14
8.47
8.89
8.02
8.31
8.93
7.95
9.36
9.29
7.27
6.59
3.53
Tangible Book Value per Share
-10.26
-10.39
-10.55
-12.35
-11.81
-13.02
-12.43
-13.53
-13.1
-15.01
-17.34
-20.91
-25.7
Basic Weighted Avg Shares
296
296
294
292
285
277
270
265
260
255
245
238
231
Sales/Revenue/Turnover
3,565
3,660
4,208
4,286
4,368
4,259
4,612
4,603
4,771
5,453
5,584
5,916
6,125
Operating Margin (%)
16.27
15.6
16.35
17.94
18.41
19.04
19.67
21.29
21.82
23.18
23.82
27.05
27.54
Depreciation Expense
316
332
377
360
396
433
421
423
421
432
445
454
463
Net Income, GAAP
345
473
423
489
636
656
669
721
728
1,027
1,007
1,079
1,308
Effective Tax Rate (%)
27.96
7.42
21.96
25.19
12.26
26.29
22.03
23.05
21.64
19.51
22.36
21.7
20.68
Profit Margin (%)
9.68
12.92
10.05
11.41
14.56
15.4
14.51
15.66
15.26
18.83
18.03
18.24
21.36
Working Capital
-912
-477
-459
-856
-1,116
-1,275
-1,204
-968
-318
-892
-1,036
-1,127
-1,425
LT Debt
1,893
2,273
2,297
2,314
2,209
2,249
2,111
2,568
3,049
2,830
3,081
3,646
4,155
Total Equity
1,584
2,121
2,477
2,564
2,261
2,254
2,380
2,087
2,417
2,310
1,749
1,545
798
Return on Invested Capital (%)
10.2
12.07
11.29
11.05
12.77
10.74
12.71
13.71
14.77
17.33
17.56
21.72
22.71
Return on Capital (%)
10.47
12.71
10.41
10.68
13.15
13.08
13.47
14.59
14.37
18.83
18.77
20.82
24.7
Return on Common Equity (%)
22.24
25.78
18.48
19.44
26.41
29.08
28.87
32.28
32.33
43.45
49.62
65.51
111.65

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-8.83%
-14.58%
-48.35%
Free Cash Flow
7.25%
7.19%
0.85%
Net Income, GAAP
12.7%
13.69%
21.22%
Sales/Revenue/Turnover
3.92%
5.96%
3.53%
Total Cash Common Dividend
8.37%
11.02%
8.06%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
5,584
2024
- -
- -
- -
- -
5,916
2025
- -
- -
- -
- -
6,125

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
4.11
2024
- -
- -
- -
- -
4.54
2025
- -
- -
- -
- -
5.66

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.91
2024
- -
- -
- -
- -
2.19
2025
- -
- -
- -
- -
2.44

Company Description

CEO
Stacey Caywood
Full Time Employees
20,567
Sector
Technology
Industry
Software - Application
Address
Zuidpoolsingel 2 Alphen aan den Rijn ZH Netherlands 2400 BA
IPO Date
Dec 16, 2010
Business
Wolters Kluwer N.V. provides professional information, software solutions, and services to accountants, lawyers, doctors, tax professionals, and other specialists in the healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG sectors. The company offers core products including UpToDate and Lippincott for clinical decision support in health; CCH Axcess, CCH ProSystem fx, and CCH AnswerConnect for tax preparation and accounting; Westlaw and VitalLaw for legal research; CT Corporation and TeamMate for compliance and audit; Enablon for environmental health and safety; CCH Tagetik for corporate performance management; and Brightflag for legal spend management; complemented by services such as workflow tools, publications, and AI-enabled platforms across these categories. Wolters Kluwer operates in over 180 countries with a primary focus on North America, Europe, and Asia-Pacific markets serving professionals, corporations, government entities, and healthcare providers. Founded in 1836 and headquartered in Alphen aan den Rijn, Netherlands, the company maintains corporate offices in Philadelphia, United States, and employs approximately 21,600 people worldwide. Recent strategic developments include the 2024 acquisition of Isabel Group's accountancy portfolio—featuring CodaBox, ClearFacts, Clearnox, Zoomit, and Flowin—for €325 million to enhance European cloud-based financial workflows; the 2025 acquisitions of Registered Agent Solutions (RASi) for mid-market compliance services, Brightflag for €425 million to bolster AI-powered legal operations among mid-sized U.S. and European corporations, and Libra Technology for legal AI capabilities; partnerships such as with Microsoft for healthcare integrations and Enterprise Health for EHS solutions; and the divestment of its Finance, Risk & Regulatory Reporting unit. In 2025, Wolters Kluwer advances its 2025-2027 strategic plan by scaling expert solutions with generative and agentic AI integrations, accelerating growth through acquisitions and partnerships, and evolving go-to-market capabilities, as evidenced by first-half revenues of €3.1 billion and recurring cloud software growth of 15% organically.

Company News

  • Wolters Kluwer collaborates with Finago to connect financial workflows for accounting firms and businesses in Sweden

  • Wolters Kluwer partners with Hitachi Cyber to deliver integrated governance, risk and compliance solutions

  • New Wolters Kluwer Health Prior Authorization and Claims Processing Optimization Tools Help Payers Meet Tighter Regulatory Timelines, Reduce High Appeal Overturn Rates

  • Wolters Kluwer and Dentsu Soken Deliver CCH® Tagetik as Daihatsu Motor's Budget Management System

  • Wolters Kluwer Transforms Trusted Legal Content Into Structured, AI-Ready Intelligence That Powers the Next Wave of Legal AI

  • Wolters Kluwer Study Identifies Seven-Year High in Subpoena Volumes

  • Wolters Kluwer Brings Trusted Medi-Span Medication Intelligence to Growing Veterinary Drug Market

  • Health System Adoption of Wolters Kluwer UpToDate Expert AI Now Reaching Approximately 2,500 U.S. Hospitals and Health Systems

  • Wolters Kluwer 2026 Half-Year Report

  • Wolters Kluwer to Help Rural Hospitals and FQHCs Access Top Drug Information and Patient Education Solutions Integrated With Epic

  • Norway's health system adopts Wolters Kluwer UpToDate Enterprise Edition

  • Wolters Kluwer named the Premier Leader in BPM Partners Vendor Landscape Matrix for the fourth consecutive year

  • Wolters Kluwer Named Top Vendor Law Firm SaaS Solution Provider in the DACH Region for 2027

  • Wolters Kluwer: An Undervalued Compounder Trading At A Discount

  • Wolters Kluwer: The Business Of Truth That AI Cannot Replace

  • Wolters Kluwer successfully prices €500 million 7-year Eurobond

  • Wolters Kluwer leads the next era of tax and accounting with agentic AI innovations at AICPA ENGAGE

  • Wolters Kluwer expands its Libra AI workspace with authoritative Swiss legal content from leading publisher Stämpfli

  • Wolters Kluwer executive, Cathy Rowe, delivers address at AICPA ENGAGE highlighting AI-driven transformation of the accounting profession

  • Wolters Kluwer helps multinational enterprises and tax advisors meet Australia's first BEPS Pillar Two filing deadline as penalties and scrutiny loom